106 related articles for article (PubMed ID: 5182604)
1. Polarizing solution and intrathecal methylprednisolone acetate in multiple sclerosis: follow-up study.
Beck RH
J Am Osteopath Assoc; 1967 Feb; 66(6):664-6. PubMed ID: 5182604
[No Abstract] [Full Text] [Related]
2. Polarizing solutions and intrathecal methylprednisolone acetate in therapy of multiple sclerosis: preliminary study.
De Vito SJ; Mannarelli AA
J Am Osteopath Assoc; 1966 Mar; 65(7):713-22. PubMed ID: 5175985
[No Abstract] [Full Text] [Related]
3. [Our experiences in the treatment of multiple sclerosis by intrathecal administration of methylprednisolone acetate and follow-up of the cerebrospinal fluid changes during this treatment].
Jedlicka P; Kupka J; Kocinová F
Cesk Neurol Neurochir; 1975 Dec; 38(6):338-45. PubMed ID: 1104205
[No Abstract] [Full Text] [Related]
4. [Multiple sclerosis. Clinico-statistical results of therapy based on intrathecal methylprednisolone acetate].
Sbarbaro V; Girelli Bruni E; Monaco V; Gasperini GF; Zardini GB; Brogi L
Minerva Med; 1974 Sep; 65(65):3407-11. PubMed ID: 4479023
[No Abstract] [Full Text] [Related]
5. Intrathecal methylprednisolone acetate in multiple sclerosis treatment. Clinical evaluation.
Mazzarello P; Poloni M; Piccolo G; Cosi V; Pinelli P
Acta Neurol Belg; 1983; 83(4):190-6. PubMed ID: 6689244
[TBL] [Abstract][Full Text] [Related]
6. [Methylprednisolone acetate in intrathecal administration in multiple sclerosis].
Palchetti R; Giunta A; Tortoli V; Scarpelli PT
Rass Neurol Veg; 1965 Jun; 19(3):243-8. PubMed ID: 5899668
[No Abstract] [Full Text] [Related]
7. [Lumbar intrathecal injection of methylprednisolone acetate in the treatment of multiple sclerosis].
Delzanno GB; Jann G
Clin Ter; 1969 Jan; 48(2):151-5. PubMed ID: 5409031
[No Abstract] [Full Text] [Related]
8. [Our contemporary experiences with the intrathecal treatment of multiple sclerosis using depot corticoids. I. Clinical results].
Hanák L; Zouhar A
Cesk Neurol Neurochir; 1974 Sep; 37(5):287-92. PubMed ID: 4479028
[No Abstract] [Full Text] [Related]
9. [Polarizing solution in myocardial infarct].
Parás Chavero E; Gómez Lepe A; Barrera Tenorio EF
Arch Inst Cardiol Mex; 1967; 37(3):330-8. PubMed ID: 6057344
[No Abstract] [Full Text] [Related]
10. Intrathecal methylprednisolone for multiple sclerosis: evaluation by a standard neurological rating.
Baker AG
Ann Allergy; 1967 Dec; 25(12):665-72. PubMed ID: 6072742
[No Abstract] [Full Text] [Related]
11. [The treatment of patients with myocardial infarct with potassium chloride and polarizing solution].
Gorb GD
Vrach Delo; 1966 Aug; 8():147-9. PubMed ID: 5989149
[No Abstract] [Full Text] [Related]
12. The treatment of multiple sclerosis with intrathecally administered methylprednisolone acetate.
Ringer WA
J Indiana State Med Assoc; 1968 Sep; 61(9):1213-5. PubMed ID: 5695699
[No Abstract] [Full Text] [Related]
13. Complications from methylprednisolone acetate (Depo-Medrol) when injected into the orbit, subarachnoid, or subdural spaces.
Abel R; Nelson DA; Bernat JL
Del Med J; 1977 Jun; 49(6):331-43. PubMed ID: 577483
[No Abstract] [Full Text] [Related]
14. Experimental intrathecal administration of methylprednisolone acetate in multiple sclerosis.
Goldstein NP; McGuckin WF; McKenzie BF; Mattox VR
Trans Am Neurol Assoc; 1970; 95():243-4. PubMed ID: 5537958
[No Abstract] [Full Text] [Related]
15. [Considerations on intrathecal administration of corticosteroids in case of multiple sclerosis].
Cendrowski W
Wiad Lek; 1976 Feb; 29(3):193-6. PubMed ID: 946336
[No Abstract] [Full Text] [Related]
16. [Our contemporary experiences with the intrathecal treatment of multiple sclerosis using depot corticoids. II. Results in cerebrospinal fluid].
Hrazdira CL; Mandzjuk B; Skálová M
Cesk Neurol Neurochir; 1974 Sep; 37(5):293-300. PubMed ID: 4479029
[No Abstract] [Full Text] [Related]
17. Efficacy of intravenous polarizing solutions: the effect of intracellular potassium concentration and transmembrane potential in clinical patients.
Burchett GD
J Am Osteopath Assoc; 1968 Oct; 68(2):174-9. PubMed ID: 5188544
[No Abstract] [Full Text] [Related]
18. [Polarizing solutions--glucose-potassium-insulin--for heart infarct].
Bleifeld W; Effert S; Merx W
Dtsch Med J; 1970 May; 21(10):690 passim. PubMed ID: 5523168
[No Abstract] [Full Text] [Related]
19. [Polarizing mixtures in emergency cardiology].
Matveĭkov GP; Ziuzenkov MV
Ter Arkh; 1976; 48(10):32-8. PubMed ID: 139703
[No Abstract] [Full Text] [Related]
20. [The concentration of potassium and sodium in the plasma, erythrocytes and urine of myocardial infarct patients following administration of polarizing mixtures].
Gorkun MA
Vrach Delo; 1972 Jun; 6():93-5. PubMed ID: 5043620
[No Abstract] [Full Text] [Related]
[Next] [New Search]
